The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAeorema Comm. Regulatory News (AEO)

Share Price Information for Aeorema Comm. (AEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.50
Bid: 60.00
Ask: 65.00
Change: 1.00 (1.63%)
Spread: 5.00 (8.333%)
Open: 61.50
High: 62.50
Low: 61.50
Prev. Close: 61.50
AEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Dec 2016 09:06

RNS Number : 0805R
Aeorema Communications Plc
06 December 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Aeorema Communications Plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

   

 

3. Full name of person(s) subject to the notification obligation: iii

Rupert Labrum

4. Full name of shareholder(s)

(if different from 3.): iv

 

5. Date of the transaction and date on which the threshold is crossed or reached: v

05/12/2016

6. Date on which issuer notified:

05/12/2016

7. Threshold(s) that is/are crossed or

reached: vi, vii

3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B4QHH456

 

Below 3%

Below 3%

300000

300000

 

3.314

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

 

 

 

 

 

Nominal

Delta

 

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 300000

3.314

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 Rupert Labrum

14. Contact name:

 

15. Contact telephone number:

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGGPUPUPQUBQ
Date   Source Headline
25th Apr 20247:00 amRNSCheerful Twentyfirst wins at the 2024 Ex Awards
24th Apr 20247:00 amRNSPresenting at Mello Results Show
22nd Apr 20247:00 amRNSMajor Contract Renewed & Award Nomination
12th Apr 20247:00 amRNSInvestor Presentation
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirectors’ Dealing
27th Mar 20242:54 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim Results and FY Projections
5th Mar 20247:00 amRNSAgency Winners Of Creative Team Of The Year Award
6th Feb 20242:12 pmRNSHolding(s) in Company
14th Dec 202312:00 pmRNSResult of AGM
29th Nov 20237:00 amRNSCheerful Twentyfirst Wins Leading Industry Award
24th Nov 20237:00 amRNSPresenting at MelloLondon Investor Conference
23rd Nov 20237:00 amRNSNotice of Investor Presentation
20th Nov 20237:00 amRNSNotice of AGM and Posting of Annual Report
14th Nov 20237:00 amRNSFinal Results
11th Oct 20239:00 amRNSGrant of Options
18th Sep 20237:00 amRNSPresenting at MelloMonday Investor Event
26th Jul 20239:46 amRNSCheerful Twentyfirst Appoints US President
25th Jul 20237:00 amRNSTrading Update: Strong revenue & profit growth
21st Jul 202312:00 pmRNSInvestor Presentation
21st Jul 202310:00 amRNSHolding(s) in Company
17th Jul 20237:00 amRNSCheerful Twentyfirst Wins Multiple Industry Awards
28th Jun 20237:00 amRNSEventful Update – Promotion to Managing Director
3rd May 202310:06 amRNSHolding(s) in Company
18th Apr 20239:27 amRNSHolding(s) in Company
17th Apr 20233:04 pmRNSDirectors' Dealings
13th Apr 20237:00 amRNSDirectors’ Dealings
11th Apr 20231:12 pmRNSResult Of General Meeting
6th Apr 20234:15 pmRNSDirectors Shareholding - Replacement
6th Apr 20232:48 pmRNSDirector Shareholding
6th Apr 202310:03 amRNSHolding(s) in Company
29th Mar 20233:00 pmRNSInterim Results - Replacement
29th Mar 20237:00 amRNSInterim Results
21st Mar 20237:00 amRNSNotice Of General Meeting
13th Mar 20237:00 amRNSAgency Winners Of Creative Team of the Year
3rd Mar 202312:23 pmRNSHolding(s) in Company
1st Mar 20231:25 pmRNSTrading Update - Double Digit Revenue Growth
15th Feb 20232:13 pmRNSHolding(s) in Company
19th Jan 20232:17 pmRNSMajor Contract - Stagwell Cannes Lions Partnership
30th Dec 20221:00 pmRNSTotal Voting Rights
16th Dec 20224:34 pmRNSExercise of Options
15th Dec 202212:19 pmRNSResult of AGM
21st Nov 20227:00 amRNSNotice of AGM and Posting of Annual Report
14th Nov 20227:00 amRNSFinal Results
21st Oct 20227:00 amRNSGrant of Options
18th Aug 20227:00 amRNSTrading Update & Amsterdam Office
15th Jul 202210:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.